Delivery Order SPE2DB22D1106-SPE2DB25FFCG0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Albuterol HFA 90 MCG Inhaler in 8.5GM units, valued at $1,518.96. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of August 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order valued at $1,863.66 to AmerisourceBergen Drug Corp for the supply of Albuterol HFA 90 MCG Inhaler 8.5GM, with an ultimate completion date of July 31, 2025. The contract utilizes firm fixed pricing and was awarded without a set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Albuterol HFA 90 MCG Inhalers (8.5 GM) with a ceiling value of $1,373.40. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The contract is set to complete by July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award falls...
- The Defense Logistics Agency awarded a $358,160 delivery order to Amerisourcebergen Drug Corporation for the supply of albuterol HFA 90 mcg inhalers. The firm fixed price order is for the delivery of 8.5 grams of the inhalers to a location in Conshohocken, Pennsylvania by June 30, 2023. The prime contractor, Amerisourcebergen Drug Corporation, will fulfill the order from its Corporate Office Division. As the Defense Logistics Agency is responsible for worldwide logistics support of the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,609.68 firm-fixed-price contract is for the delivery of 4,567,104,771 units of the albuterol HFA 90 mcg inhaler with an ultimate completion date of January 31, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
- The Defense Logistics Agency awarded a $353,170 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562229820 albuterol HFA 90 mcg inhalers. The single award delivery order, issued under an unspecified governmentwide acquisition contract, calls for Amerisourcebergen to deliver 18 grams of the inhalers to a location in Conshohocken, Pennsylvania by September 20, 2023. As a major provider of pharmaceuticals and medical supplies to the U.S. military and other...
- The Defense Logistics Agency awarded a $425,000 delivery order to Amerisourcebergen Drug Corporation for the supply of 90 microgram albuterol HFA inhalers. The firm fixed price contract calls for the delivery of approximately 8.5 grams of the inhalers to a location in Conshohocken, Pennsylvania by August 22, 2023 in support of DLA programs. Amerisourcebergen will serve as the prime contractor to fulfill this requirement for respiratory medications. No subcontractors or set aside designations...
- The Defense Logistics Agency awarded a $282 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561899759 ALBUTEROL HFA 90 MCG INHALERS. As the prime contractor, Amerisourcebergen will deliver approximately 8.5 grams of the inhalers to a facility in Conshohocken, Pennsylvania under a one-day period of performance beginning on August 22, 2023. The ordering activity is procuring the inhalers to support the medical readiness programs of the Department of Defense....
- The Defense Logistics Agency awarded a $483,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of albuterol HFA 90 mcg inhalers. The contract calls for Amerisourcebergen to deliver 8.5 grams of the inhalers to a location in Conshohocken, Pennsylvania by August 28, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for respiratory medications likely supports DLA's mission to provide critical medical...
- The Defense Logistics Agency awarded a $393,360 delivery order to Amerisourcebergen Drug Corporation for the supply of albuterol HFA 90 mcg inhalers. As part of its mission to provide logistics support to the Department of Defense, the Defense Logistics Agency issued this firm fixed price order under an indefinite-delivery/indefinite-quantity contract vehicle. Amerisourcebergen will deliver 8.5 grams of the inhalers to a facility in Conshohocken, Pennsylvania by August 9, 2023 to support the...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFCG0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,063.72 to AmerisourceBergen Drug Corp for the supply of Albuterol HFA 90 mcg inhaler in 8.5 gram units. This competitively awarded, firm fixed-price delivery order was issued on August 8, 2025, with an ultimate completion date of August 11, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's Corporate Office is headquartered. As a non-set-aside contract, this award was made through open competition, reflecting the company's established capability to meet federal medical procurement requirements. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. That prime contract serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a vast range of medications, vaccines, and medical supplies to support military healthcare programs globally. The current delivery order for Albuterol inhalers represents a routine fulfillment within this broader agreement, supporting the Defense Health Agency and other federal healthcare systems' respiratory medication needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/8/25 |